Neuroprem: the Neuro-developmental outcome of very low birth weight infants in an Italian region.


Journal

Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759

Informations de publication

Date de publication:
22 Feb 2020
Historique:
received: 14 08 2019
accepted: 07 02 2020
entrez: 24 2 2020
pubmed: 24 2 2020
medline: 3 2 2021
Statut: epublish

Résumé

The survival of preterm babies has increased worldwide, but the risk of neuro-developmental disabilities remains high, which is of concern to both the public and professionals. The early identification of children at risk of neuro-developmental disabilities may increase access to intervention, potentially influencing the outcome. Neuroprem is an area-based prospective cohort study on the neuro-developmental outcome of very low birth weight (VLBW) infants that aims to define severe functional disability at 2 years of age. Surviving VLBW infants from an Italian network of 7 neonatal intensive care units (NICUs) were assessed for 24 months through the Griffiths Mental Developmental Scales (GMDS-R) or the Bayley Scales of Infant and Toddler Development (BSDI III) and neuro-functional evaluation according to the International Classification of Disability and Health (ICF-CY). The primary outcome measure was severe functional disability at 2 years of age, defined as cerebral palsy, a BSDI III cognitive composite score < 2 standard deviation (SD) or a GMDS-R global quotients score < 2 SD, bilateral blindness or deafness. Among 211 surviving VLBW infants, 153 completed follow-up at 24 months (72.5%). Thirteen patients (8.5%) developed a severe functional disability, of whom 7 presented with cerebral palsy (overall rate of 4.5%). Patients with cerebral palsy were all classified with ICF-CY scores of 3 or 4. BSDI III composite scores and GMDS-R subscales were significantly correlated with ICF-CY scores (p < 0.01). Neuroprem represents an Italian network of NICUs aiming to work together to ensure preterm neuro-developmental assessment. This study updates information on VLBW outcomes in an Italian region, showing a rate of cerebral palsy and major developmental disabilities in line with or even lower than those of similar international studies. Therefore, Neuroprem provides encouraging data on VLBW neurological outcomes and supports the implementation of a preterm follow-up programme from a national network perspective.

Identifiants

pubmed: 32087748
doi: 10.1186/s13052-020-0787-7
pii: 10.1186/s13052-020-0787-7
pmc: PMC7036238
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

26

Subventions

Organisme : Fondazione Pierfranco e Luisa Mariani
ID : NEUROPREM

Références

Res Dev Disabil. 2016 Jan;48:132-44
pubmed: 26555385
Res Dev Disabil. 2016 Aug;55:173-84
pubmed: 27101093
Pediatrics. 2009 Jun;123(6):1485-92
pubmed: 19482758
Early Hum Dev. 2013 Oct;89(10):825-31
pubmed: 23916325
Lancet. 2008 Mar 8;371(9615):813-20
pubmed: 18328928
Disabil Health J. 2014 Oct;7(4):433-41
pubmed: 25224983
Ment Retard Dev Disabil Res Rev. 2005;11(1):34-51
pubmed: 15856442
Dev Med Child Neurol. 2016 Mar;58 Suppl 4:67-73
pubmed: 27027610
J Matern Fetal Neonatal Med. 2013 Nov;26(16):1653-7
pubmed: 23570550
PLoS One. 2011;6(7):e21361
pubmed: 21760892
BMJ. 2017 Aug 16;358:j3448
pubmed: 28814566
Eur J Paediatr Neurol. 2012 May;16(3):243-7
pubmed: 21944394
BMJ. 2012 Dec 04;345:e7961
pubmed: 23212880
Dev Disabil Res Rev. 2011;17(2):102-13
pubmed: 23362030
J Matern Fetal Neonatal Med. 2017 Jan;30(1):96-102
pubmed: 26957041
Dev Neurorehabil. 2009 Feb;12(1):3-11
pubmed: 19283529
Pediatrics. 2007 Oct;120(4):793-804
pubmed: 17908767
Arch Dis Child Fetal Neonatal Ed. 2012 May;97(3):F167-73
pubmed: 22215800
Dev Med Child Neurol. 2007 Mar;49(3):166
pubmed: 17355470
N Engl J Med. 2017 Feb 16;376(7):617-628
pubmed: 28199816
Int J Rehabil Res. 2016 Dec;39(4):296-301
pubmed: 27362970
JAMA. 2013 May 1;309(17):1810-20
pubmed: 23632725

Auteurs

Licia Lugli (L)

Neonatal Intensive Care Unit, University Hospital of Modena, Via del Pozzo 71, 41100, Modena, Italy. licia.lugli@virgilio.it.

Marisa Pugliese (M)

Neonatal Intensive Care Unit, University Hospital of Modena, Via del Pozzo 71, 41100, Modena, Italy.

Carlotta Plessi (C)

Neonatal Intensive Care Unit, University Hospital of Modena, Via del Pozzo 71, 41100, Modena, Italy.

Alberto Berardi (A)

Neonatal Intensive Care Unit, University Hospital of Modena, Via del Pozzo 71, 41100, Modena, Italy.

Isotta Guidotti (I)

Neonatal Intensive Care Unit, University Hospital of Modena, Via del Pozzo 71, 41100, Modena, Italy.

Gina Ancora (G)

Neonatal Intensive Care Unit, Infermi Hospital of Rimini, Rimini, Italy.

Sara Grandi (S)

Neonatal Intensive Care Unit, Infermi Hospital of Rimini, Rimini, Italy.

Giancarlo Gargano (G)

Neonatal Intensive Care Unit, Santa Maria Nuova Hospital of Reggio Emilia, Reggio Emilia, Italy.

Silvia Braibanti (S)

Neonatal Intensive Care Unit, Santa Maria Nuova Hospital of Reggio Emilia, Reggio Emilia, Italy.

Fabrizio Sandri (F)

Neonatal Intensive Care Unit, Maggiore Hospital of Bologna, Bologna, Italy.

Silvia Soffritti (S)

Neonatal Intensive Care Unit, Maggiore Hospital of Bologna, Bologna, Italy.

Elisa Ballardini (E)

Neonatal Intensive Care Unit, Sant'Anna Hospital of Ferrara, Sant'Anna, Italy.

Vittoria Arena (V)

Neonatal Intensive Care Unit, Sant'Anna Hospital of Ferrara, Sant'Anna, Italy.

Marcello Stella (M)

Neonatal Intensive Care Unit, Bufalini Hospital of Cesena, Cesena, Italy.

Serafina Perrone (S)

Neonatal Intensive Care Unit, University Hospital of Parma, Parma, Italy.

Sabrina Moretti (S)

Neonatal Intensive Care Unit, University Hospital of Parma, Parma, Italy.

Vittoria Rizzo (V)

Neonatal Intensive Care Unit, Bufalini Hospital of Cesena, Cesena, Italy.

Fabrizio Ferrari (F)

Neonatal Intensive Care Unit, University Hospital of Modena, Via del Pozzo 71, 41100, Modena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH